| [1] | Huang Q.Q., Wigdor E.M., Malawsky D.S., et al. (2024). Examining the role of common variants in rare neurodevelopmental conditions. Nature 636:404−411. DOI:10.1038/s41586-024-08217-y |
| [2] | Niemi M.E.K., Martin H.C., Rice D.L., et al. (2018). Common genetic variants contribute to risk of rare severe neurodevelopmental disorders. Nature 562:268−271. DOI:10.1038/s41586-018-0566-4 |
| [3] | Wang S., Zhou X., Ma Y., et al. (2024). Gut-to-brain neuromodulation by synthetic butyrate-producing commensal bacteria. The Innovation Life 2:100082. DOI:10.59717/j.xinn-life.2024.100082 |
| [4] | Hu J.-R., Abdullah A., Nanna M.G., et al. (2023). The brain–heart axis: Neuroinflammatory interactions in cardiovascular disease. Curr. Cardiol. Rep. 25:1745−1758. DOI:10.1007/s11886-023-01990-8 |
| [5] | Zhao B., Li T., Fan Z., et al. (2023). Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images. Science 380:abn6598. DOI:10.1126/science.abn6598 |
| Wang S., He M., Chen X., et al. (2025). Unveiling genetic substrates of brain–heart comorbidities: Integration of both common and rare variants. The Innovation Life 3:100118. https://doi.org/10.59717/j.xinn-life.2024.100118 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Schematic illustration of how common and rare genetic variants act synergistically to modify the risk of brain–heart comorbidities